LabEx DEVweCAN France

Research

Date range: 1 April 2021 - 31 March 2022

Region: Global
Subject/journal group: All

The table to the right includes counts of all research outputs for LabEx DEVweCAN published between 1 April 2021 - 31 March 2022 which are tracked by the Nature Index.

Hover over the donut graph to view the Share for each subject. Below, the same research outputs are grouped by subject. Click on the subject to drill-down into a list of articles organized by journal, and then by title.

Note: Articles may be assigned to more than one subject area.

Article Count and Share for LabEx DEVweCAN
Count Share
33 5.05

Outputs by subject (Share)

Outputs by subject
Subject Count Share
2 1.01
32 4.05
1 0.04

Share output for the past 5 years

Share per year
2016 2017 2018 2019 2020
6.21 3.58 6.15 4.25 5.45

Compare LabEx DEVweCAN with other institutions

Collaboration

Date range: 1 April 2021 - 31 March 2022

International vs. domestic collaboration by Share

  • 64.02% Domestic
  • 35.98% International

Hover over the graph to view the percentage of collaboration.

Top 10 domestic collaborators with LabEx DEVweCAN by Share (90 total)

  1. LabEx DEVweCAN and University of Lyon (8.24)
    LabEx DEVweCAN4.66
    University of Lyon3.58
  2. LabEx DEVweCAN and National Institute for Health and Medical Research (INSERM) (7.09)
    LabEx DEVweCAN4.66
    National Institute for Health and Medical Research (INSERM)2.43
  3. LabEx DEVweCAN and French National Centre for Scientific Research (CNRS) (7.06)
    LabEx DEVweCAN4.66
    French National Centre for Scientific Research (CNRS)2.40
  4. LabEx DEVweCAN and Centre Léon Bérard (CLB) (6.23)
    LabEx DEVweCAN4.66
    Centre Léon Bérard (CLB)1.58
  5. LabEx DEVweCAN and Lyon University Hospital (HCL) (6.16)
    LabEx DEVweCAN4.66
    Lyon University Hospital (HCL)1.50
  6. LabEx DEVweCAN and International Center for Infectiology Research (CIRI) (2.87)
    LabEx DEVweCAN0.96
    International Center for Infectiology Research (CIRI)1.91
  7. LabEx DEVweCAN and Ligue Contre Le Cancer (1.49)
    LabEx DEVweCAN0.95
    Ligue Contre Le Cancer0.54
  8. LabEx DEVweCAN and Netris Pharma S.A.S. (1.09)
    LabEx DEVweCAN0.93
    Netris Pharma S.A.S.0.16
  9. LabEx DEVweCAN and The French Alternative Energies and Atomic Energy Commission (CEA) (0.96)
    LabEx DEVweCAN0.89
    The French Alternative Energies and Atomic Energy Commission (CEA)0.07
  10. LabEx DEVweCAN and Sorbonne University (0.79)
    LabEx DEVweCAN0.63
    Sorbonne University0.16

Top 10 international collaborators with LabEx DEVweCAN by Share (124 total)

  1. LabEx DEVweCAN and University of Oxford (3.20)
    LabEx DEVweCAN0.24
    University of Oxford2.96
  2. LabEx DEVweCAN and The Peter Doherty Institute for Infection and Immunity (Doherty Institute) (1.21)
    LabEx DEVweCAN0.12
    The Peter Doherty Institute for Infection and Immunity (Doherty Institute)1.09
  3. LabEx DEVweCAN and Max Planck Society (1.14)
    LabEx DEVweCAN0.50
    Max Planck Society0.64
  4. LabEx DEVweCAN and Xiamen University (XMU) (1.00)
    LabEx DEVweCAN0.09
    Xiamen University (XMU)0.91
  5. LabEx DEVweCAN and Leibniz Association (0.86)
    LabEx DEVweCAN0.04
    Leibniz Association0.82
  6. LabEx DEVweCAN and Washington University in St. Louis (WUSTL) (0.85)
    LabEx DEVweCAN0.19
    Washington University in St. Louis (WUSTL)0.67
  7. LabEx DEVweCAN and Queen Mary University of London (QMUL) (0.76)
    LabEx DEVweCAN0.06
    Queen Mary University of London (QMUL)0.71
  8. LabEx DEVweCAN and Amsterdam Movement Sciences (0.76)
    LabEx DEVweCAN0.14
    Amsterdam Movement Sciences0.62
  9. LabEx DEVweCAN and King's College London (KCL) (0.76)
    LabEx DEVweCAN0.64
    King's College London (KCL)0.12
  10. LabEx DEVweCAN and The University of Melbourne (UniMelb) (0.75)
    LabEx DEVweCAN0.12
    The University of Melbourne (UniMelb)0.63

Relationships

LabEx DEVweCAN

Partner Institutions

LabEx DEVweCAN is a research collaboration whose article contributions are accrued to its participating partner institutions below.


Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.